These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10974155)

  • 1. Measuring receptor occupancy with PET.
    Waarde Av
    Curr Pharm Des; 2000 Nov; 6(16):1593-610. PubMed ID: 10974155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring drug-related receptor occupancy with positron emission tomography.
    Passchier J; Gee A; Willemsen A; Vaalburg W; van Waarde A
    Methods; 2002 Jul; 27(3):278-86. PubMed ID: 12183116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
    Gründer G; Yokoi F; Offord SJ; Ravert HT; Dannals RF; Salzmann JK; Szymanski S; Wilson PD; Howard DR; Wong DF
    Neuropsychopharmacology; 1997 Sep; 17(3):175-85. PubMed ID: 9272484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
    Okubo Y; Suhara T
    Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects.
    Nyberg S; Farde L; Halldin C
    Neuropsychopharmacology; 1997 Jan; 16(1):1-7. PubMed ID: 8981383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor Occupancy Imaging Studies in Oncology Drug Development.
    Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
    AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action.
    Fischman AJ; Alpert NM; Rubin RH
    Clin Pharmacokinet; 2002; 41(8):581-602. PubMed ID: 12102642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.
    Nyberg S; Nordström AL; Halldin C; Farde L
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():81-5. PubMed ID: 8866769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
    Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration--a positron emission tomography study.
    Kanerva H; Vilkman H; Någren K; Kilkku O; Kuoppamäki M; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 1999 Jul; 145(1):76-81. PubMed ID: 10445375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G
    Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
    Mazière B; Delforge J
    Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptor imaging and neuroleptic drug response.
    Heinz A; Knable MB; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 11():84-8; discussion 89-93. PubMed ID: 8941175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.
    Knauer CS; Campbell JE; Galvan B; Bowman C; Osgood S; Buist S; Buchholz L; Henry B; Wong EH; Shahid M; Grimwood S
    Eur J Pharmacol; 2008 Sep; 591(1-3):136-41. PubMed ID: 18593577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain.
    Farde L; Andrée B; Ginovart N; Halldin C; Thorberg S
    Neuropsychopharmacology; 2000 Apr; 22(4):422-9. PubMed ID: 10700661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of positron emission tomography in pharmacokinetic analysis.
    Fischman AJ; Alpert NM; Babich JW; Rubin RH
    Drug Metab Rev; 1997 Nov; 29(4):923-56. PubMed ID: 9421680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-receptor interactions as studied by PET: implications for drug development.
    Hietala J
    Ann Med; 1999 Dec; 31(6):438-43. PubMed ID: 10680859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2003 Mar; 166(3):234-40. PubMed ID: 12589516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of neuroleptics on human brain estimated by SPECT and PET].
    Hatazawa J
    Kaku Igaku; 1993 Jun; 30(6):687-92. PubMed ID: 8102187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.